This site contains promotional information intended only for healthcare professionals resident in the United Kingdom

Visit Pfizer Medical site
Search

Menu

Close

Sign In or RegisterLog Out
Pfizer MedicinesTherapy AreasExplore ContentEventsVideosMaterialsFeatured ArticlesLet’s ConnectSupplyAlliance HealthcareOff-contract claims

Example content

Adverse event reporting can be found at the bottom of the page

Key Insights in Paediatric Endocrinology

Prescribing information can be found at the bottom of the page.


Join us on 23 May 2024 to hear from Professor Paul Dimitri, Consultant in Paediatric Endocrinology, Professor Indi Banerjee, Consultant in Paediatric Endocrinology, Dr Sanjay Gupta, Consultant in Paediatric Endocrinology, Dr Charlotte Elder, Consultant in Paediatric Endocrinology and Professor Jo Blair, Consultant in Paediatric Endocrinology discussing 'Key Insights in Paediatric Endocrinology' followed by a live interactive Q&A.

This promotional meeting is organised and funded by Pfizer Ltd for UK HCP's and may include reference to medicines or vaccines promoted by Pfizer. 

Prescribing information can be found at the bottom of the page.


Join us on 23 May 2024 to hear from Professor Paul Dimitri, Consultant in Paediatric Endocrinology, Professor Indi Banerjee, Consultant in Paediatric Endocrinology, Dr Sanjay Gupta, Consultant in Paediatric Endocrinology, Dr Charlotte Elder, Consultant in Paediatric Endocrinology and Professor Jo Blair, Consultant in Paediatric Endocrinology discussing 'Key Insights in Paediatric Endocrinology' followed by a live interactive Q&A.

This promotional meeting is organised and funded by Pfizer Ltd for UK HCP's and may include reference to medicines or vaccines promoted by Pfizer. 

Event Date23 May 2024 14:00 BSTDuration3 Hrs 20 AudienceConsultants, Nurses, Pharmacists, Specialist Registrars {{givenName}}%20{{familyName}}%20has%20shared%20a%20resource%20with%20you%3B%20please%20click%20the%20link%20below%3A%0D%0A%0D%0A{{URL}}%0D%0A%0D%0AThank%20you%2C%0D%0A{{givenName}}%20{{familyName}}
Agenda
Meeting Agenda 13:45 - 14:00Arrival & Registration
14:00 - 14:05Welcome & Introduction Iajaz Satti & Aqssa Ayyaz, Pfizer Ltd
14:05 - 14:25Long-Term Efficacy and Safety of Once-Weekly Somatrogon in Paediatric Subjects With Growth Hormone Deficiency: Results From up to 8 years of Somatrogon Treatment Paul Dimitri - Professor
14:25 - 14:30Questions & Answers Paul Dimitri - Professor
14:30 - 15:00Congenital Hyperinsulinism In Childhood Indi Banerjee - Professor
15:00 - 15:10Questions & Answers Indi Banerjee - Professor
15:10 - 15:40Ngenla (somatrogon) Long Acting Growth Hormone Clinical & Patient Experience Sanjay Gupta - Dr
15:40 - 15:50Questions & Answers Sanjay Gupta - Dr
15:50 - 16:00Refreshment Break
16:00 - 16:30Paediatric and Adolescent Gynaecology Updates Charlotte Elder - Dr
16:30 - 16:40Questions & Answers Charlotte Elder - Dr
16:40 - 17:10Clinical Presentation of Genetic Endocrine Tumour Syndromes in Childhood Jo Blair - Professor
17:10 - 17:20Questions & Answers Jo Blair - Professor
17:20 - 17:30Meeting Summary Paul Dimitri - Professor
17:30Meeting Close
Speakers
Event Speakers
Paul Dimitri, Professor
Paul Dimitri, ProfessorConsultant in Paediatric Endocrinology, Sheffield Children's Hospital

No Biography Available

Indi Banerjee, Professor
Indi Banerjee, ProfessorConsultant in Paediatric Endocrinology, Manchester Children's Hospital

No Biography Available

Sanjay Gupta, Dr
Sanjay Gupta, DrConsultant in Paediatric Endocrinology, Hull University Hospital

No Biography Available

Charlotte Elder, Dr
Charlotte Elder, DrConsultant in Paediatric Endocrinology, Sheffield Children's Hospital

No Biography Available

Jo Blair, Professor
Jo Blair, ProfessorConsultant in Paediatric Endocrinology, Alder Hey Children's Hospital

No Biography Available

Ngenla®(somatrogon) 

Prescribing Information

Genotropin®(somatropin rbe) 

Prescribing Information

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Pfizer Medical Information on 01304 616161.

PP-NGE-GBR-0801. May 2024

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search 

for MHRA Yellow Card in Google Play or Apple App Store

 

Adverse events should also be reported to Pfizer Medical Information on 01304 616161

PfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign In or RegisterAccountSign Out

This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc

 

This website is brought to you by Pfizer Limited, a company registered in England 

and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ

 

Copyright © 2024 Pfizer Limited. All rights reserved.

 

VAT registration number GB201048427

PP-UNP-GBR-7866. January 2024
For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-UNP-GBR-7812. January 2024

YesNo
You are now leaving PfizerPro​​​​​

​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site.​​​​​​​​​​​​​​

​​​​​​​PP-PFE-GBR-3858. November 2021​​​​​​​
​​​​​​​
You are now leaving PfizerPro
​​​​​​​
​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to ​​​​​Pfizer medicines or 
business which it has provided or reviewed.

PP-PFE-GBR-3859. November 2021
​​​​​​​